Literature DB >> 8831946

Glucose and glutamine metabolism in C6 glioma cells studied by carbon 13 NMR.

J C Portais1, P Voisin, M Merle, P Canioni.   

Abstract

The question as to whether glutamine and glucose are both required for optimal growth of glioma cells is studied through the role of these substrates on the metabolism of the cells. C6 rat glioma cells grow only very slowly when glutamine is omitted from the culture medium. The rates of glucose consumption and lactate production on confluent cells in glutamine-free medium were 0.88 +/- 0.09 and 1.06 +/- 0.25 mumol/h/mg protein, respectively. In the presence of 4 mM glutamine, glucose utilization increase to 60% leading to a 45% increase of lactate production. We have studied the kinetics of enrichment of intracellular glutamate at C2, C3 and C4 positions on cells incubated with 5 mM 99% enriched [1-(13)C]glucose in the presence or the absence of glutamine in the incubation medium. The specific enrichments at metabolic steady state of all carbon positions were the same under both conditions, but we observed a significantly reduced rate of 13C incorporation in the presence of glutamine, showing an isotopic dilution of tricarboxylic acid cycle intermediates and indicating the use of this amino acid as an anaplerotic substrate. The fact that no dilution occurred at the level of pyruvate suggests strongly the lack of glutaminolysis in these cells. The main conclusion from this work is that glutamine metabolism in C6 cells appears complementary to that of glucose as far as energy production and carbon sources for the growing of the cells are concerned: glutamine is mainly utilized for anaplerosis as carbon donor to replenish the tricarboxylic acid cycle; it is not a substrate for energy metabolism. In contrast, glucose is poorly anaplerotic and is essentially used as energetic fuel by the C6 cells.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8831946     DOI: 10.1016/0300-9084(96)89500-9

Source DB:  PubMed          Journal:  Biochimie        ISSN: 0300-9084            Impact factor:   4.079


  32 in total

1.  Energetic and morphological plasticity of C6 glioma cells grown on 3-D support; effect of transient glutamine deprivation.

Authors:  M Martin; B Beauvoit; P J Voisin; P Canioni; B Guérin; M Rigoulet
Journal:  J Bioenerg Biomembr       Date:  1998-12       Impact factor: 2.945

Review 2.  Brick by brick: metabolism and tumor cell growth.

Authors:  Ralph J Deberardinis; Nabil Sayed; Dara Ditsworth; Craig B Thompson
Journal:  Curr Opin Genet Dev       Date:  2008-04-02       Impact factor: 5.578

3.  Contribution of extracellular glutamine as an anaplerotic substrate to neuronal metabolism: a re-evaluation by multinuclear NMR spectroscopy in primary cultured neurons.

Authors:  Touraj Shokati; Claudia Zwingmann; Dieter Leibfritz
Journal:  Neurochem Res       Date:  2005-10       Impact factor: 3.996

4.  Glutaminolysis is required for transforming growth factor-β1-induced myofibroblast differentiation and activation.

Authors:  Karen Bernard; Naomi J Logsdon; Gloria A Benavides; Yan Sanders; Jianhua Zhang; Victor M Darley-Usmar; Victor J Thannickal
Journal:  J Biol Chem       Date:  2017-12-08       Impact factor: 5.157

5.  Single-cell analysis demonstrates how nutrient deprivation creates apoptotic and quiescent cell populations in tumor cylindroids.

Authors:  Byoung-Jin Kim; Neil S Forbes
Journal:  Biotechnol Bioeng       Date:  2008-11-01       Impact factor: 4.530

6.  Microglia in close vicinity of glioma cells: correlation between phenotype and metabolic alterations.

Authors:  Pierre Voisin; Véronique Bouchaud; Michel Merle; Philippe Diolez; Laura Duffy; Kristian Flint; Jean-Michel Franconi; Anne-Karine Bouzier-Sore
Journal:  Front Neuroenergetics       Date:  2010-10-12

Review 7.  Isotope enhanced approaches in metabolomics.

Authors:  G A Nagana Gowda; Narasimhamurthy Shanaiah; Daniel Raftery
Journal:  Adv Exp Med Biol       Date:  2012       Impact factor: 2.622

Review 8.  Autophagy: a targetable linchpin of cancer cell metabolism.

Authors:  Robert D Leone; Ravi K Amaravadi
Journal:  Trends Endocrinol Metab       Date:  2013-03-06       Impact factor: 12.015

Review 9.  Prospects for clinical cancer metabolomics using stable isotope tracers.

Authors:  Andrew N Lane; Teresa W-M Fan; Richard M Higashi; Jinlian Tan; Michael Bousamra; Donald M Miller
Journal:  Exp Mol Pathol       Date:  2009-01-20       Impact factor: 3.362

10.  THZ1 suppresses human non-small-cell lung cancer cells in vitro through interference with cancer metabolism.

Authors:  Zhu-Jun Cheng; Du-Ling Miao; Qiu-Yun Su; Xiao-Li Tang; Xiao-Lei Wang; Li-Bin Deng; Hui-Dong Shi; Hong-Bo Xin
Journal:  Acta Pharmacol Sin       Date:  2018-11-16       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.